GSA Capital Partners LLP cut its stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 62.9% in the ...

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) has been given an average recommendation of “Moderate Buy” by the ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell ...

Amplitude ( AMPL -1.76%) is one such example. The software-as-a-service stock, which specializes in digital analytics and ...

Amazon wants to dominate the three core layers of artificial intelligence: infrastructure, large language models, and software.

Shares of Applied Digital surged in extended trading Thursday after Nvidia reported a stake in the company. Nvidia held a ...

Detailed price information for Acadia Pharmaceutica (ACAD-Q) from The Globe and Mail including charting and trades.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The stock currently trades at just under $18.00 a share and sports an approximate market capitalization of $2.95 billion.

the Australian Stock Exchange was told in a statement Monday. The 100 per cent takeover price was a premium of around 23 per cent over the closing price of Eumundi shares on October 29 ($1.26) when ...

In a report released today, Jay Olson from Oppenheimer maintained a Hold rating on ACADIA Pharmaceuticals (ACAD – Research Report), with ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.76% of ...